Statement on Compliance with Articles 11, 43, and 44 of the Measures for Major Asset Reorganization of Listed Companies

Anhui Hongyu Wuzhou Medical Device Co., Ltd. Board of Directors

Statement on Compliance with Articles 11, 43, and 44 of the Measures for Major Asset Reorganization of Listed Companies

Anhui Hongyu Wuzhou Medical Device Co., Ltd. (hereinafter referred to as the "Company") held the 13th meeting of its Third Board of Directors on July 20, 2026, and reviewed and approved the "Proposal on the Company's Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Party Transactions" and its summary. The Company plans to acquire 100% of the equity held by all shareholders of Xuanzhi Electronic Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Xuanzhi Technology" or the "Target Company") through the issuance of shares and payment of cash, and plans to raise supporting funds by issuing shares to no more than 35 specific investors (hereinafter referred to as the "Transaction"). For details, please refer to the relevant announcements disclosed by the Company on the Juchao Information Network (www.cninfo.com.cn).

The Company's Board of Directors makes the following statement on whether the Transaction complies with Articles 11, 43, and 44 of the Measures for Major Asset Reorganization of Listed Companies (hereinafter referred to as the "Reorganization Measures"):

I. The Transaction Complies with Article 11 of the Reorganization Measures